Clarametyx COO Dr. Veronica Hall shares her perspective on how the newly announced agreement with CARB-X helps to support our platform strategy and accelerate development in an area of high unmet need in infectious disease. https://lnkd.in/em6azQ85
Congrats!Veronica! All the best!
Inspiring! Great work!!
Congrats Veronica!
Congrats to Clarametyx. Full speed ahead.
Translational Research | Product Development | Strategic Partnerships | Collaboration Management | External Innovation | Infectious Diseases R&D (antivirals, mAbs, and vaccines)
2moCongratulations Veronica and the Clarametyx team on this exciting agreement with CARB-X!